# Efficacy of NAC for the Prevention and Relief of PIPN in Women With Ovarian, Tubal, and Peritoneal Cancer

> **NCT05539053** · NA · COMPLETED · sponsor: **Department of Medical Services Ministry of Public Health of Thailand** · enrollment: 60 (actual)

## Conditions studied

- Chemotherapy-induced Peripheral Neuropathy

## Interventions

- **DRUG:** N Acetylcysteine A
- **DRUG:** N Acetylcysteine B

## Key facts

- **NCT ID:** NCT05539053
- **Lead sponsor:** Department of Medical Services Ministry of Public Health of Thailand
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-01
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05539053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05539053, "Efficacy of NAC for the Prevention and Relief of PIPN in Women With Ovarian, Tubal, and Peritoneal Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05539053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*